RXi Q1 Losses Down, R&D Expenses Up

RXi said it expects its resources will be sufficient to fund operations “through at least the first quarter of 2012.”

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories